Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus

Journal of Virological Methods

Volumn 129, Issue 1, 2005, Pages 56-63

  Ivens, Tania ^a   Van Den Eynde, Christel ^a   Van Acker, Koen ^a   Nijs, Erik ^a   Dams, Géry ^a   Bettens, Eva ^a   Ohagen, Asa ^a   Pauwels, Rudi ^a   Hertogs, Kurt ^a  

^a TIBOTEC BVBA   (Belgium)

Author keywords

Antiviral activity; EGFP expression; High throughput screening; SARS CoV

Indexed keywords

ANTIVIRUS AGENT; AURINTRICARBOXYLIC ACID; DEXTRAN SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENHANCED GREEN FLUORESCENT PROTEIN; GLYCYRRHIZIC ACID; LOPINAVIR PLUS RITONAVIR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N ACETYL S NITROSOPENICILLAMINE; NOVARON; PROTEIN INHIBITOR; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; AUTOMATION; BIOASSAY; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SPECIFICITY; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; SARS CORONAVIRUS; SCREENING TEST; SEVERE ACUTE RESPIRATORY SYNDROME; SWINE; TRANSMISSIBLE GASTROENTERITIS VIRUS; VERO CELL;

ANTIVIRAL AGENTS; CELL LINE; DRUG EVALUATION, PRECLINICAL; GREEN FLUORESCENT PROTEINS; SARS VIRUS; VIRUS REPLICATION;

CORONAVIRUS; SARS COV; SUIDAE; TRANSMISSIBLE GASTROENTERITIS VIRUS;

EID: 24044438961     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.05.010     Document Type: Article

References (26)

1. A. Balasubramanian, R.K. Ganju, and J.E. Groopman Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes J. Biol. Chem. 278 2003 35755 35766
2. C.M. Chu, V.C.C. Cheng, I.F.N. Hung, M.M.L. Wong, K.H. Chan, K.S. Chan, R.Y.T. Kao, L.L.M. Poon, C.L.P. Wong, Y. Guan, J.S.M. Peiris, K.Y. Yuen HKU/UCH SARS Study Group Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Thorax 59 2004 252 256
3. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H.W. Doerr Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Lancet 361 2003 2045 2046
4. M. Cushman, and P. Sherman Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions Biochem. Biophys. Res. Commun. 185 1992 85 90
5. C.A.M. De Haan, H. Volders, C.A. Koetzner, P.M. Masters, and P.J.M. Rottier Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization J. Virol. 76 2002 12491 12502
6. P.A. Furman, J.A. Fyfe, M.H. St Clair, K. Weinhold, J.L. Rideout, G.A. Freeman, S.N. Lehrman, D.P. Bolognesi, S. Broder, H. Mitsuya, and D.W. Barry Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase Proc. Natl. Acad. Sci. USA 83 1986 8333 8337
7. T. Hertzig, E. Scandella, B. Schelle, J. Ziebuhr, S.G. Siddell, B. Ludewig, and V. Thiel Repid identification of coronavirus replicase inhibitors using a selectable replicon RNA J. Gen. Virol. 85 2004 1717 1725
8. E. Keyaerts, L. Vijgen, L. Chen, P. Maes, G. Hedenstierna, and M. Van Ranst Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N- acetylpenicillamine, a nitric oxide donor compound Int. J. Infect. Dis. 8 2004 223 226
9. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell, A.E. Ling, C.D. Humphrey, W.J. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. DeRisi, J.Y. Yang, N. Cox, J.M. Hughes, J.W. LeDuc, W.J. Bellini, L.J. Anderson SARS Working Group A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 2003 1953 1966
10. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, H.-Y. Choe, and M. Farzan Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 2003 450 454
11. S. Liu, G. Xiao, Y. Chen, Y. He, J. Niu, C.R. Escalante, H. Xiong, J. Farmar, A.K. Debnath, P. Tien, and S. Jiang Interaction between heptad repeat one and two regions in spike protein of SARS-associated coronavirus: implications for its fusogenic mechanism and identification of fusion inhibitors Lancet 363 2004 938 947
12. E.M. Mangum, and K.K. Graham Lopinavir-Ritonavir: a new protease inhibitor Pharmacotherapy 21 2001 1352 1363
13. S. Ray, S.L. Broor, Y. Vaishnav, C. Sarkar, R. Girish, L. Dar, P. Seth, and S. Broor Transforming growth factor beta in hepatitis C virus infection in vivo and in vitro findings J. Gastroenterol. Hepatol. 18 2003 393 403
14. D. Schols, R. Pauwels, J. Desmyter, and E. De Clercq Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1 Virology 175 1990 556 561
15. L.K.-Y. So, A.C.W. Lau, L.Y.C. Yam, T.M.T. Cheung, E. Poon, R.W.H. Yung, and K.Y. Yuen Development of a standard treatment protocol for severe acute respiratory syndrome Lancet 361 2003 1615 1617
16. E.L. Tan, E.E. Ooi, C.Y. Lin, H.C. Tan, A.E. Ling, B. Lim, and L.W. Stanton Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs Emerg. Infect. Dis. 10 2004 581 586
17. V. Thiel, K.A. Ivanov, A. Putics, T. Hertzig, B. Schelle, S. Bayer, B. Weissbrich, E.J. Snijder, H. Rabenau, H.W. Doerr, A.E. Gorbalenya, and J. Ziebuhr Mechanisms and enzymes involved in SARS coronavirus genome expression J. Gen. Virol. 84 2003 2305 2315
18. Toagosei Co. Ltd., 2003. News Release, Prous Daily Essentials, November 17.
19. B. Vastag Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS JAMA 290 2003 1695 1696
20. C.Y. Wu, J.T. Jan, S.H. Ma, C.J. Kuo, H.F. Juan, Y.S. Cheng, H.H. Hsu, H.C. Huang, D. Wu, A. Brik, F.S. Liang, R.S. Liu, J.M. Fang, S.T. Chen, P.H. Liang, and C.H. Wong Small molecules targeting severe acute respiratory syndrome human coronavirus Proc. Natl. Acad. Sci. USA 101 2004 10012 10017
21. Y. Xu, Y. Liu, Z. Lou, L. Qin, X. Li, Z. Bai, H. Pang, P. Tien, G.F. Gao, and Z. Rao Structural basis for coronavirus-mediated membrane fusion: crystal structure of MHV spike protein fusion core J. Biol. Chem. 279 2004 30514 30522
22. N. Yamamoto, R. Yang, Y. Yoshinaka, S. Amari, T. Nakano, J. Cinatl, H. Rabenau, H.W. Doerr, G. Hunsmann, A. Otaka, H. Tamamura, N. Fujii, and N. Yamamoto HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus Biochem. Biophys. Res. Commun. 318 2004 719 725
23. L. Yi, Z. Li, K. Yuan, X. Qu, J. Chen, G. Wang, H. Zhang, H. Luo, L. Zhu, P. Jiang, L. Chen, Y. Shen, M. Luo, G. Zuo, J. Hu, D. Duan, Y. Nie, X. Shi, W. Wang, Y. Han, T. Li, Y. Liu, M. Ding, H. Deng, and X. Xu Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells J. Virol. 78 2004 11334 11339
24. K. Yoshida, M. Tanagawa, and M. Atsuta Characterization and inhibitory effect of antibacterial dental resin composites incorporating silver-supported materials J. Biomed. Mater. Res. 47 1999 516 522
25. J. Zhang, E. Balestrieri, S. Grelli, C. Matteucci, V. Pagnini, C. D'Agostini, A. Mastino, and B. Macchi Efficacy of 3′-azido 3′deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells Virus Res. 78 2001 67 78
26. Y. Zhang, D. Schols, and E. De Clercq Selective activity of various antiviral compounds against HHV-7 infection Antiviral Res. 43 1999 23 35